8-37965251-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000025.3(ADRB3):c.1205+14G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0844 in 1,501,686 control chromosomes in the GnomAD database, including 5,857 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.091 ( 748 hom., cov: 33)
Exomes 𝑓: 0.084 ( 5109 hom. )
Consequence
ADRB3
NM_000025.3 intron
NM_000025.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.323
Genes affected
ADRB3 (HGNC:288): (adrenoceptor beta 3) The protein encoded by this gene belongs to the family of beta adrenergic receptors, which mediate catecholamine-induced activation of adenylate cyclase through the action of G proteins. This receptor is located mainly in the adipose tissue and is involved in the regulation of lipolysis and thermogenesis. Obesity and bodyweight-related disorders are correlated with certain polymorphisms in three subtypes of beta-adrenoceptor, among them, the ADRB3 gene.[provided by RefSeq, Oct 2019]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 8-37965251-C-A is Benign according to our data. Variant chr8-37965251-C-A is described in ClinVar as [Benign]. Clinvar id is 1230608.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.136 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADRB3 | NM_000025.3 | c.1205+14G>T | intron_variant | ENST00000345060.5 | NP_000016.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADRB3 | ENST00000345060.5 | c.1205+14G>T | intron_variant | 1 | NM_000025.3 | ENSP00000343782.3 | ||||
ENSG00000285880 | ENST00000647937.1 | c.689+14G>T | intron_variant | ENSP00000497740.1 | ||||||
ADRB3 | ENST00000520341.2 | n.1347G>T | non_coding_transcript_exon_variant | 1/1 | 6 |
Frequencies
GnomAD3 genomes AF: 0.0910 AC: 13852AN: 152178Hom.: 740 Cov.: 33
GnomAD3 genomes
AF:
AC:
13852
AN:
152178
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0934 AC: 10921AN: 116978Hom.: 618 AF XY: 0.0897 AC XY: 5764AN XY: 64266
GnomAD3 exomes
AF:
AC:
10921
AN:
116978
Hom.:
AF XY:
AC XY:
5764
AN XY:
64266
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0837 AC: 112911AN: 1349392Hom.: 5109 Cov.: 31 AF XY: 0.0840 AC XY: 55808AN XY: 664276
GnomAD4 exome
AF:
AC:
112911
AN:
1349392
Hom.:
Cov.:
31
AF XY:
AC XY:
55808
AN XY:
664276
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0912 AC: 13896AN: 152294Hom.: 748 Cov.: 33 AF XY: 0.0933 AC XY: 6949AN XY: 74466
GnomAD4 genome
AF:
AC:
13896
AN:
152294
Hom.:
Cov.:
33
AF XY:
AC XY:
6949
AN XY:
74466
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
500
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 18, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at